201 related articles for article (PubMed ID: 37090107)
1. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
PeerJ; 2023; 11():e15203. PubMed ID: 37090107
[TBL] [Abstract][Full Text] [Related]
2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
[TBL] [Abstract][Full Text] [Related]
4. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
5. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
6. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
Liu S; Wang S; Wang Z
BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
[TBL] [Abstract][Full Text] [Related]
8. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer.
Li LY; Yang Q; Jiang YY; Yang W; Jiang Y; Li X; Hazawa M; Zhou B; Huang GW; Xu XE; Gery S; Zhang Y; Ding LW; Ho AS; Zumsteg ZS; Wang MR; Fullwood MJ; Freedland SJ; Meltzer SJ; Xu LY; Li EM; Koeffler HP; Lin DC
Nat Commun; 2021 Jul; 12(1):4362. PubMed ID: 34272396
[TBL] [Abstract][Full Text] [Related]
9. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
10. MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
Xing J; Gu Y; Song Y; Liu Q; Chen Q; Han P; Shen Z; Li H; Zhang S; Bai Y; Ma J; Sui F
BMC Cancer; 2023 Dec; 23(1):1267. PubMed ID: 38129784
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of Fingolimod on Head and Neck Squamous Cell Carcinoma and Its Mechanism: Gene Set Enrichment Analysis.
Chang L; Xie C; Chou K; Meng Q; Zhao L
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):150-157. PubMed ID: 37715396
[TBL] [Abstract][Full Text] [Related]
12. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
15. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS12, a novel prognostic predictor, promotes cell proliferation, migration, and invasion in head and neck squamous cell carcinoma.
Li M; Yuan Z; Tang Z
Oral Dis; 2024 Mar; 30(2):235-246. PubMed ID: 36222542
[TBL] [Abstract][Full Text] [Related]
17. Biomarker Potential of
Ju Y; Zhu F; Fang B
Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
[TBL] [Abstract][Full Text] [Related]
18. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
[TBL] [Abstract][Full Text] [Related]
19. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
20. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
